Tradewinds Universal, Inc. reported that its recently filed Annual Report on Form 10-K for the year ended December 31, 2025 did not include a required auditor consent. The missing consent relates to the report of Astra Audit & Advisory, the company’s independent registered public accounting firm for December 31, 2024.
The company is working with Astra Audit & Advisory to obtain this consent as promptly as practicable. Once received, it plans to file the consent with the SEC and may amend the 2025 Form 10-K solely to add the consent. The company is also evaluating how the omitted consent affects any effective registration statements that incorporate the original Form 10-K by reference.
Tradewinds Universal reported 2025 revenue of $133,222, down from $171,596 in 2024, as it shifted away from physical protein bar sales toward licensing and distribution rights. With no cost of goods sold, gross margin reached 100%, but operating expenses surged to $1,026,099, driven mainly by consulting and stock-based compensation.
The company recorded a 2025 net loss of $892,877 and ended the year with total assets of $307,333, including $216,500 in intangible assets, and cash of $16,638. Accumulated deficit rose to $1,183,067, and auditors highlighted substantial doubt about its ability to continue as a going concern.
Strategically, Tradewinds is focusing on licensing its canine pain relief formula, selling distribution and licensing rights, and pursuing new verticals. In August 2025 it signed a Letter of Intent with Peppermint Hippo™ to enter the nightlife and hospitality sector. Subsequent to year-end, it entered a $10.0 million common stock purchase agreement with RH2 Equity Partners to provide potential future equity funding.
Tradewinds Universal notified the SEC that its Annual Report on Form 10-K for the period ended December 31, 2025 will be filed late. The company says it needs additional time "for compilation and review to insure adequate disclosure" and states the report "will be filed on or before the 15th calendar day following the prescribed due date." The notification is signed by CEO Andrew Read on March 31, 2026.
Tradewinds Universal has filed an S-1 to register the resale of up to 20,000,000 shares of common stock by RH2 Equity Partners under a committed equity facility. The company itself is not selling shares in this prospectus, but may raise up to $10,000,000 by selling stock to RH2 at its discretion under a separate purchase agreement.
As of January 29, 2026, Tradewinds had 43,690,580 common shares outstanding, trading on OTCMarkets under the symbol TRWD at $0.10 per share. The company is an early-stage holding company built around insect-protein nutrition products and a canine pain-relief formula, and has signed a letter of intent to expand into nightlife and hospitality through Peppermint Hippo-branded venues.
The filing highlights limited operating history, recurring net losses, tight liquidity, dependence on CEO Andrew Read, and significant potential dilution from equity financing. Shares are classified as penny stock, which can reduce trading liquidity and make it harder for investors to resell their holdings.
Tradewinds Universal (TRWD) filed its Q3 2025 10‑Q, reporting higher quarterly sales but a larger loss and a going‑concern warning. Q3 sales were $65,450 versus $28,068 a year ago, driven by distribution rights. Q3 net loss widened to $108,199 from $36,547 as consulting and professional fees rose.
For the nine months, sales were $98,422 versus $146,179 last year, reflecting the shift away from UP protein bar product sales and affiliate commissions. Nine‑month net loss was $134,454 compared to $102,249. Cash was $7,161 at September 30, 2025. Total assets increased to $316,556, mainly from $222,700 of intangible assets (including a $200,000 AI application acquired for 173,913 shares). Stockholders’ equity was $312,056.
The company disclosed substantial doubt about its ability to continue as a going concern and noted disclosure controls were not effective as of September 30, 2025. Shares outstanding were 36,610,580 as of November 14, 2025. Management highlighted an August 2025 LOI with Peppermint Hippo to enter nightlife and hospitality, starting with the planned acquisition of Peppermint Hippo Toledo.